Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3β-Hydroxysteroid Dehydrogenase (3βHSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3βHSD Deficiency Disorder1
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
We identified two homozygous missense mutations in the human type II 3β-hydroxysteroid dehydrogenase (3βHSD) gene, the first in codon 6 of exon II [CTT (Leu) to TTT (Phe)] in a male infant with hyperpigmented scrotum and hypospadias, raised as a male and no apparent salt-wasting since neonatal age, and the second in codon 259 of exon IV [ACG (Thr) to ATG (Met)] in a male pseudohermaphrodite with labial scrotal folds, microphallus, chordee, and fourth degree hypospadias, raised as a female and with salt-wasting disorder since neonatal age. In vitro transient expression of mutant type II 3βHSD complementary DNAs of L6F, T259M, as well as T259R for comparison was examined by a site-directed mutagenesis and transfection of construct into COS-1 and COS-7 cells. Northern blot analysis revealed expression of similar amounts of type II 3βHSD messenger ribonucleic acid from the COS-1 cells transfected by L6F, T259M, T259R, and wild-type (WT) complementary DNAs. Western immunoblot analysis revealed a similar amount of L6F mutant protein compared to WT enzyme from COS-1 cells, but neither L6F from COS-7 cells nor T259M or T259R mutant protein in COS-1 or COS-7 cells was detectable. Enzyme activity in intact COS-1 cells using 1 μmol/L pregnenolone as substrate in the medium after 6 h revealed relative conversion rates of pregnenolone to progesterone of 46% by WT enzyme, 22% by L6F enzyme, and 8% by T259M enzyme and less than 4% activity by T259R enzyme. Using 1 μmol/L dehydroepiandrosterone as substrate, the relative conversion rate of dehydroepiandrosterone to androstenedione after 6 was 89% by WT enzyme, 35% by L6F enzyme, 5.1% by T259M enzyme and no activity by T259R enzyme. However, the L6F mutant 3βHSD activity, despite its demonstration in the intact cells, was not detected in homogenates of COS-1 cells or in immunoblots of COS-7 cells, suggestive of the relatively unstable nature of this protein in vitro, possibly attributable to the decreased 3βHSD activity. In the case of T259M and T259R mutations, consistently undetectable proteins in both COS cells despite detectable messenger ribonucleic acids indicate severely labile proteins resulting in either no or very little enzyme activity, and these data further substantiate the deleterious effect of a structural change in this predicted putative steroid-binding domain of the gene. In conclusion, the findings of the in vitro study of mutant type II 3βHSD enzyme activities correlated with a less severe clinical phenotype of nonsalt-wasting and a lesser degree of genital ambiguity in the patient with homozygous L6F mutation compared to a more severe clinical phenotype of salt-wasting and severe degree of genital ambiguity in the patient with homozygous T259M mutation in the gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rhéaume, E., Lachance, Y., Zhao, H.-F., Breton, N., Dumont, M., Launoit, Y. D., Trudel, C., Luu-The, V., Simard, J., & Labrie, F. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1147 · Cited by 362
The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase
Bongiovanni, A. M. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104666 · Cited by 304
Rhéaume, E., Simard, J., Morel, Y., Mebarki, F., Zachmann, M., Forest, M. G., New, M. I., & Labrie, F. (1992) · Nature Genetics · doi:10.1038/ng0792-239 · Cited by 235
Structural Analysis of the Gene Encoding Human 3β-Hydroxysteroid Dehydrogenase/δ5→4-lsomerase
Lorence, M. C., Corbin, C. J., Kamimura, N., Mahendroo, M. S., & Mason, J. I. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1850 · Cited by 80
Self-citationChang, Y. T., Kappy, M. S., Iwamoto, K., Wang, J., Yang, X., & Pang, S. (1993) · Pediatric Research · doi:10.1203/00006450-199311000-00026 · Cited by 44
Self-citationSimard, J., Sanchez, R., Durocher, F., Rhéaume, E., Turgeon, C., Labrie, Y., Luu-The, V., Mebarki, F., Morel, Y., de Launoit, Y., et al. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00198-0 · Cited by 24
Cited by
Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
Mermejo, L. M., Elias, L. L. K., Marui, S., Moreira, A. C., Mendonca, B. B., & de Castro, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1552 · Cited by 91
Kösel, S., Burggraf, S., Fingerhut, R., Dörr, H. G., Roscher, A. A., & Olgemöller, B. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042416 · Cited by 52
Silveira, E., Elnecave, R., Dos Santos, E., Moura, V, Pinto, E., Van Der Linden Nader, I., Mendonca, B., & Bachega, T. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01274.x · Cited by 31
Metadata
- Authors
- Zhang, L., Mason, J. I., Naiki, Y., Copeland, K. C., Castro-Magana, M., Gordon-Walker, T. T., Chang, Y. T., & Pang, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-04-01
- Volume
- 85
- Issue
- 4
- Pages
- 1678-1685
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2170926281
- Cited by
- 29
- References
- 6
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3β-Hydroxysteroid Dehydrogenase (3βHSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3βHSD Deficiency Disorder1. https://app.cochat.ai/papers/10.1210/jcem.85.4.6539
- The paper
- Zhang, L., Mason, J. I., Naiki, Y., Copeland, K. C., Castro-Magana, M., Gordon-Walker, T. T., Chang, Y. T., & Pang, S. (2000). Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3β-Hydroxysteroid Dehydrogenase (3βHSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3βHSD Deficiency Disorder1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.85.4.6539
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.